Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Wollenberg

Showing results (141-150 of 222) with videos related to

Pageof 23
Sort By:
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|August 9, 2016
Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeksDirk Rades, Primoz Strojan, Daniel Seidl, et al.
Pharmacological Research|February 14, 2024
Isothiocyanates in medicine: A comprehensive review on phenylethyl-, allyl-, and benzyl-isothiocyanatesCosima C Hoch, Maria Shoykhet, Tobias Weiser, et al.
Cancers|February 25, 2022
NOTCH1 Intracellular Domain and the Tumor Microenvironment as Prognostic Markers in HNSCCBenedikt Schmidl, Michael Siegl, Melanie Boxberg, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 1, 2016
Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancersDirk Rades, Daniel Seidl, Stefan Janssen, et al.
Deutsches Arzteblatt International|January 9, 2026
The Treatment of Vertigo With a Digital Health App: Findings of the Prospective Randomized Controlled GEVE-I TrialMarkus Wirth, Jannik Pieper, Ulrike Heller, et al.
Cancer Research|October 16, 2003
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancerEvelyn Hartmann, Barbara Wollenberg, Simon Rothenfusser, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 20, 2002
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitorStephan Lang, Lina Lauffer, Christoph Clausen, et al.
Oral Oncology|July 18, 2016
Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?Dirk Rades, Daniel Seidl, Stefan Janssen, et al.
Clinical and Vaccine Immunology : CVI|August 25, 2006
Analysis of plasmacytoid and myeloid dendritic cells in nasal epitheliumEvelyn Hartmann, Hendrik Graefe, Anne Hopert, et al.
Experimental Gerontology|March 15, 2023
The profile of circulating extracellular vesicles depending on the age of the donor potentially drives the rejuvenation or senescence fate of hematopoietic stem cellsParvaneh Abbasi Sourki, Ali Akbar Pourfathollah, Saeed Kaviani, et al.
Pageof 23

Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|August 9, 2016
Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeksDirk Rades, Primoz Strojan, Daniel Seidl, et al.
Pharmacological Research|February 14, 2024
Isothiocyanates in medicine: A comprehensive review on phenylethyl-, allyl-, and benzyl-isothiocyanatesCosima C Hoch, Maria Shoykhet, Tobias Weiser, et al.
Cancers|February 25, 2022
NOTCH1 Intracellular Domain and the Tumor Microenvironment as Prognostic Markers in HNSCCBenedikt Schmidl, Michael Siegl, Melanie Boxberg, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 1, 2016
Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancersDirk Rades, Daniel Seidl, Stefan Janssen, et al.
Deutsches Arzteblatt International|January 9, 2026
The Treatment of Vertigo With a Digital Health App: Findings of the Prospective Randomized Controlled GEVE-I TrialMarkus Wirth, Jannik Pieper, Ulrike Heller, et al.
Cancer Research|October 16, 2003
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancerEvelyn Hartmann, Barbara Wollenberg, Simon Rothenfusser, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 20, 2002
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitorStephan Lang, Lina Lauffer, Christoph Clausen, et al.
Oral Oncology|July 18, 2016
Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?Dirk Rades, Daniel Seidl, Stefan Janssen, et al.
Clinical and Vaccine Immunology : CVI|August 25, 2006
Analysis of plasmacytoid and myeloid dendritic cells in nasal epitheliumEvelyn Hartmann, Hendrik Graefe, Anne Hopert, et al.
Experimental Gerontology|March 15, 2023
The profile of circulating extracellular vesicles depending on the age of the donor potentially drives the rejuvenation or senescence fate of hematopoietic stem cellsParvaneh Abbasi Sourki, Ali Akbar Pourfathollah, Saeed Kaviani, et al.
Pageof 23